EP2666484B1 - Liquid preparation for contact lenses - Google Patents
Liquid preparation for contact lenses Download PDFInfo
- Publication number
- EP2666484B1 EP2666484B1 EP11856120.8A EP11856120A EP2666484B1 EP 2666484 B1 EP2666484 B1 EP 2666484B1 EP 11856120 A EP11856120 A EP 11856120A EP 2666484 B1 EP2666484 B1 EP 2666484B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- contact lens
- liquid preparation
- cationic
- agent
- liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000007788 liquid Substances 0.000 title claims description 115
- 238000002360 preparation method Methods 0.000 title claims description 88
- 125000002091 cationic group Chemical group 0.000 claims description 42
- 239000002562 thickening agent Substances 0.000 claims description 36
- 229920003125 hypromellose 2910 Polymers 0.000 claims description 30
- 229940031672 hypromellose 2910 Drugs 0.000 claims description 30
- 229920001184 polypeptide Polymers 0.000 claims description 30
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 30
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 30
- 230000001954 sterilising effect Effects 0.000 claims description 28
- 238000001914 filtration Methods 0.000 claims description 25
- 239000004599 antimicrobial Substances 0.000 claims description 22
- 238000000034 method Methods 0.000 claims description 15
- 239000004094 surface-active agent Substances 0.000 claims description 15
- 108010039918 Polylysine Proteins 0.000 claims description 12
- 239000000872 buffer Substances 0.000 claims description 11
- 239000012929 tonicity agent Substances 0.000 claims description 11
- 239000002738 chelating agent Substances 0.000 claims description 10
- 239000012736 aqueous medium Substances 0.000 claims description 9
- 229920000656 polylysine Polymers 0.000 claims description 8
- 102000007327 Protamines Human genes 0.000 claims description 7
- 108010007568 Protamines Proteins 0.000 claims description 7
- 102000008186 Collagen Human genes 0.000 claims description 6
- 108010035532 Collagen Proteins 0.000 claims description 6
- 229920001436 collagen Polymers 0.000 claims description 6
- 102000011782 Keratins Human genes 0.000 claims description 5
- 108010076876 Keratins Proteins 0.000 claims description 5
- 108010073771 Soybean Proteins Proteins 0.000 claims description 5
- 235000019710 soybean protein Nutrition 0.000 claims description 5
- 239000012528 membrane Substances 0.000 claims description 4
- 229940048914 protamine Drugs 0.000 claims description 4
- 239000003002 pH adjusting agent Substances 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 55
- 238000012360 testing method Methods 0.000 description 33
- 230000000694 effects Effects 0.000 description 32
- 239000000645 desinfectant Substances 0.000 description 31
- 239000000306 component Substances 0.000 description 25
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 22
- 241000233866 Fungi Species 0.000 description 21
- 239000000243 solution Substances 0.000 description 21
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 20
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 19
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 18
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 16
- -1 hydroxypropyl groups Chemical group 0.000 description 15
- 238000012545 processing Methods 0.000 description 14
- 239000000725 suspension Substances 0.000 description 13
- 241000894006 Bacteria Species 0.000 description 12
- 230000000249 desinfective effect Effects 0.000 description 12
- 229920002451 polyvinyl alcohol Polymers 0.000 description 11
- 229920002413 Polyhexanide Polymers 0.000 description 10
- 239000004372 Polyvinyl alcohol Substances 0.000 description 10
- 229920002678 cellulose Polymers 0.000 description 10
- 239000001913 cellulose Substances 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- 230000009467 reduction Effects 0.000 description 9
- 241000222122 Candida albicans Species 0.000 description 8
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 7
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 7
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 7
- 239000000654 additive Substances 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- 230000007774 longterm Effects 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 230000000996 additive effect Effects 0.000 description 6
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 6
- 239000004327 boric acid Substances 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 229920001992 poloxamer 407 Polymers 0.000 description 6
- 229940044476 poloxamer 407 Drugs 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- 238000006467 substitution reaction Methods 0.000 description 6
- 241000224422 Acanthamoeba Species 0.000 description 5
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 5
- 239000002202 Polyethylene glycol Substances 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 229920002359 Tetronic® Polymers 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 5
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 238000010998 test method Methods 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 4
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 4
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium group Chemical group [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 4
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 4
- 229920000609 methyl cellulose Polymers 0.000 description 4
- 239000001923 methylcellulose Substances 0.000 description 4
- 235000010981 methylcellulose Nutrition 0.000 description 4
- 229960002900 methylcellulose Drugs 0.000 description 4
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 4
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 4
- 229920000053 polysorbate 80 Polymers 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 229920002307 Dextran Polymers 0.000 description 3
- 229920002907 Guar gum Polymers 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 239000000665 guar gum Substances 0.000 description 3
- 235000010417 guar gum Nutrition 0.000 description 3
- 229960002154 guar gum Drugs 0.000 description 3
- 229960003943 hypromellose Drugs 0.000 description 3
- 230000003204 osmotic effect Effects 0.000 description 3
- 229950008679 protamine sulfate Drugs 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- VAZJLPXFVQHDFB-UHFFFAOYSA-N 1-(diaminomethylidene)-2-hexylguanidine Polymers CCCCCCN=C(N)N=C(N)N VAZJLPXFVQHDFB-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- OWMVSZAMULFTJU-UHFFFAOYSA-N bis-tris Chemical compound OCCN(CCO)C(CO)(CO)CO OWMVSZAMULFTJU-UHFFFAOYSA-N 0.000 description 2
- 229920001400 block copolymer Polymers 0.000 description 2
- 229940095731 candida albicans Drugs 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229920003130 hypromellose 2208 Polymers 0.000 description 2
- 229940031707 hypromellose 2208 Drugs 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 229920000191 poly(N-vinyl pyrrolidone) Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 2
- 229940068968 polysorbate 80 Drugs 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000012487 rinsing solution Substances 0.000 description 2
- 238000013207 serial dilution Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 238000009736 wetting Methods 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- 241000224423 Acanthamoeba castellanii Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical compound NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 description 1
- 229940123208 Biguanide Drugs 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 1
- 206010015946 Eye irritation Diseases 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 239000006173 Good's buffer Substances 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 229920002004 Pluronic® R Polymers 0.000 description 1
- 229920002507 Poloxamer 124 Polymers 0.000 description 1
- 229920002511 Poloxamer 237 Polymers 0.000 description 1
- 229920002517 Poloxamer 338 Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 229920002362 Tetronic® 1304 Polymers 0.000 description 1
- GCSPRLPXTPMSTL-IBDNADADSA-N [(2s,3r,4s,5s,6r)-2-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)O[C@@]1([C@]2(CO)[C@H]([C@H](O)[C@@H](CO)O2)O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GCSPRLPXTPMSTL-IBDNADADSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229910001514 alkali metal chloride Inorganic materials 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000000607 artificial tear Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940069078 citric acid / sodium citrate Drugs 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000882 contact lens solution Substances 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002168 ethanoic acid esters Chemical class 0.000 description 1
- 231100000013 eye irritation Toxicity 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N formaldehyde Substances O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- 230000002070 germicidal effect Effects 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 231100000086 high toxicity Toxicity 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 239000005426 pharmaceutical component Substances 0.000 description 1
- 125000000914 phenoxymethylpenicillanyl group Chemical group CC1(S[C@H]2N([C@H]1C(=O)*)C([C@H]2NC(COC2=CC=CC=C2)=O)=O)C 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229940093448 poloxamer 124 Drugs 0.000 description 1
- 229920001993 poloxamer 188 Polymers 0.000 description 1
- 229940044519 poloxamer 188 Drugs 0.000 description 1
- 229920000724 poly(L-arginine) polymer Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 108010011110 polyarginine Proteins 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920000259 polyoxyethylene lauryl ether Polymers 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229950008882 polysorbate Drugs 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 238000005201 scrubbing Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- MDYZKJNTKZIUSK-UHFFFAOYSA-N tyloxapol Chemical compound O=C.C1CO1.CC(C)(C)CC(C)(C)C1=CC=C(O)C=C1 MDYZKJNTKZIUSK-UHFFFAOYSA-N 0.000 description 1
- 229920001664 tyloxapol Polymers 0.000 description 1
- 229960004224 tyloxapol Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/0005—Other compounding ingredients characterised by their effect
- C11D3/0078—Compositions for cleaning contact lenses, spectacles or lenses
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/20—Organic compounds containing oxygen
- C11D3/22—Carbohydrates or derivatives thereof
- C11D3/222—Natural or synthetic polysaccharides, e.g. cellulose, starch, gum, alginic acid or cyclodextrin
- C11D3/225—Natural or synthetic polysaccharides, e.g. cellulose, starch, gum, alginic acid or cyclodextrin etherified, e.g. CMC
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/37—Polymers
- C11D3/3703—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- C11D3/3719—Polyamides or polyimides
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/48—Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
Definitions
- the present invention relates to a liquid preparation for a contact lens, and particularly to a liquid preparation for a contact lens, which is suitably used as a composition for disinfecting a contact lens, easily produced and excellent in stability.
- Antimicrobial agent-containing liquid preparations which have hitherto been used for disinfection and the like of contact lenses are generally produced as sterile preparations, and a process of achieving sterilization thereof is usually performed by sterilization by filtration, sterilization by an autoclave or a combination thereof.
- the autoclave sterilization employs a process of performing cooling after heating at 121 °C or more. Accordingly, in the case of the liquid preparation which contains a component having low thermal stability, the autoclave sterilization cannot be employed. Further, a heat-resistant and pressure-resistant production line and cooling equipment become necessary, so that there is also an inherent demerit that the production time becomes longer due to the heating and cooling process.
- sterile processing by the filtration sterilization makes it possible to produce the liquid preparations at ordinary temperature, and has more advantages in production of the liquid preparations than the autoclave sterilization, when the liquid preparations have no problems with filterability and effects on a filter. Further, there is an advantage that foreign matter with which the liquid preparations are contaminated from raw materials and the production line can also be removed by the filter. Therefore, employment of the process of achieving sterilization by the filtration sterilization is usually studied as the first option.
- the thickening agents there are mainly used cellulose-based, guar gum-based, PVA-based and PVP-based ones, for example.
- the thickening agents which can be processed by the filtration sterilization while imparting a certain degree of thickening effect to the liquid preparations are limited to the PVA-based thickening agents and some cellulose-based thickening agents (substitution type: HPMC 2910). Of these, the PVA-based thickening agents are extremely excellent in filterability.
- liquid preparations for disinfecting contact lenses one-liquid type multi-purpose solutions in which cationic disinfectants requiring no neutralization are blended at low concentrations have become the mainstream, instead of hydrogen peroxide-based disinfectants requiring neutralization.
- cationic disinfectants used in the multi-purpose solutions two kinds of disinfectants are mainly intended: PHMB (polyhexamethylene biguanide) as a disinfectant of a biguanide-based polymer, and Polyquad as a disinfectant of a quaternary ammonium salt-based polymer.
- Polyquad is reported to have a low disinfection effect to fungi and amebas, so that it is considered that a low-molecular disinfectant having a high disinfection effect to fungi and amebas is used together with Polyquad.
- the low-molecular disinfectant has a problem of high toxicity.
- a problem caused by accumulation in the inside of lenses or the like is also a concern.
- PHMB has a high disinfection effect not only to bacteria but also to fungi and amebas, and is a well-balanced disinfectant, so that it has been used in many multi-purpose solutions.
- Patent Document 1 JP-T-8-504346 discloses a liquid preparation for a contact lens in which a polypeptide such as protamine, polyarginine or polylysine is contained in order to prevent adhesion of proteins, and exemplifies HPMC (hydroxypropyl methylcellulose) as one of barrier component coatings which constitute tablets.
- HPMC hydroxypropyl methylcellulose
- Japanese Patent No. 3813133 Patent Document 2
- Japanese Patent No. 3693656 Patent Document 3
- Japanese Patent No. 3693657 Patent Document 4
- polylysine is used as the disinfectant in a solution for disinfecting and storing a contact lens
- a POE lauryl ether type surfactant, a betaine type surfactant, sucrose laurate or the like is used together therewith in order to improve antimicrobial activity thereof.
- HPMC HPMC as the thickening agent.
- the kind of HPMC which may be used is not disclosed at all.
- Patent Document 5 discloses that in a liquid preparation for a contact lens in which polylysine is contained as the disinfectant, the thickening agent such as cellulose or a derivative thereof represented by HPMC, PVA and PVP may be contained as one of further additives.
- HPMC thickening agent
- PVA and PVP may be contained as one of further additives.
- HPMC the kind of HPMC which may be used is not disclosed at all therein.
- the present invention has been made herein in the light of such situations. It is therefore a problem to be solved by the present invention to provide a liquid preparation for disinfecting a contact lens which preparation has excellent stability and can be advantageously produced by a process employing filtration sterilization. It is another problem to be solved by the present invention to provide a method of industrially advantageously producing the liquid preparation for disinfecting a contact lens which has such excellent characteristics.
- the present invention has been completed on the basis of such findings, and the gist of the present invention is a liquid preparation for a contact lens comprising a cationic polypeptide antimicrobial agent and Hypromellose 2910 as a thickening agent, wherein a kinematic viscosity at 25°C thereof is adjusted to 0.8 mm 2 /s to 15 mm 2 /s.
- the above-mentioned cationic polypeptide antimicrobial agent is selected from the group consisting of polylysine, protamine, cationic collagen, cationic keratin, cationic soybean protein and cationic silk.
- the cationic polypeptide antimicrobial agent is contained preferably at a ratio of 0.1 ppm to 10,000 ppm.
- a tonicity agent e.g., a chelating agent, a buffer and a surfactant may be contained as needed, in addition to the above-mentioned cationic polypeptide antimicrobial agent and Hypromellose 2910.
- a pH thereof is preferably adjusted to the range of 6 to 8.
- the specific substitution type HPMC, Hypromellose 2910 is combined as the thickening agent with the cationic polypeptide antimicrobial agent, and the liquid preparation is prepared so as to have the predetermined kinematic viscosity. Accordingly, the liquid preparation for a contact lens according to the present invention is characterized in that a high disinfection effect to fungi, Acanthamoeba and the like can be maintained over a long period of time, and the liquid pH can be stably maintained over a long period of time.
- the filtration sterilization processing can be easily performed to the solution in which the cationic polypeptide antimicrobial agent and Hypromellose 2910 are dissolved and contained and which is adjusted to the predetermined kinematic viscosity, so that mass processing of the desired liquid preparation for a contact lens becomes possible, making it possible to perform the filtration sterilization processing advantageously in cost.
- the filtration sterilization process can be employed. Therefore, mass processing becomes possible, and the filtering cost for removing foreign matter and the degerming cost to fungi, Acanthamoeba and the like can be advantageously reduced, thereby being able to largely contribute to a reduction of product cost. Thus, an industrially advantageous production method has been established.
- a liquid preparation for a contact lens according to the present invention has a major characteristic in that the preparation is mainly composed of an aqueous medium in which a cationic polypeptide antimicrobial agent and Hypromellose 2910 as a thickening agent are contained, and adjusted to a predetermined kinematic viscosity.
- the cationic polypeptide antimicrobial agent used as an essential component in the present invention is known as a relatively high-molecular-weight disinfectant in a liquid preparation for disinfecting a contact lens, and components such as polylysine, protamine, cationic collagen, cationic keratin, cationic soybean protein and cationic silk are appropriately selected and used.
- the cationic polypeptide antimicrobial agent is generally contained in the liquid preparation for a contact lens at a ratio of 0.1 ppm to 10,000 ppm, and more preferably at a ratio of 1 ppm to 1,000 ppm.
- Hypromellose 2910 which is another essential component of the liquid preparation for a contact lens according to the present invention is used as the thickening agent, and is one substitution type of a cellulose-based compound (hydroxypropyl methylcellulose: HPMC) having a structure in which hydrogen atoms of hydroxyl groups of cellulose are partially substituted with methyl groups (-CH 3 ) or hydroxypropyl groups (-CH 2 CHOHCH 3 ).
- HPMC hydroxypropyl methylcellulose
- Hypromellose 2910 used in the present invention contains methoxy groups in an amount of 28.0% to 30.0% and hydroxypropoxy groups in an amount of 7.0% to 12.0%, on the weight basis.
- Hypromellose 2910 has a high degree of safety against living organisms, and is ophthalmologically sufficiently allowable, while having no influence on the shape and physical properties of the contact lens.
- the kinematic viscosity thereof at 25°C is adjusted to 0.8 mm 2 /s to 15 mm 2 /s.
- the kinematic viscosity is preferably within the range of 1 mm 2 /s to 10 mm 2 /s.
- Hypromellose 2910 is appropriately adjusted depending on the viscosity grade used. In general, Hypromellose 2910 is added and contained within the range of about 0.01 % to 10%, preferably about 0.1% to 5%, on the weight basis.
- the liquid preparation for a contact lens according to the present invention is obtained by using the cationic polypeptide antimicrobial agent and the specific cellulose-based compound, Hypromellose 2910, as the thickening agent combined therewith, adding these two components to an appropriate aqueous medium to be dissolved therein in the same manner as the conventional liquid preparation for a contact lens, and adjusting the kinematic viscosity to the specific value.
- one, two or more of additive components described later such as a tonicity agent, a chelating agent, a buffer and a surfactant which have been used in a common liquid preparation for a contact lens, may be appropriately selected and added at an ordinary addition ratio as needed, in addition to the two contained components of the cationic polypeptide antimicrobial agent and Hypromellose 2910.
- the additive components have a high degree of safety against living organisms, and are ophthalmologically sufficiently allowable, while having no influence on the shape and physical properties of the contact lens. It is desirable that the additive components are used within a quantitative range satisfying such requirements. This makes it possible to advantageously impart various functions depending on the additive components to the liquid preparation for a contact lens, without impairing the effects of the present invention in any way.
- the tonicity agent which is contained in the liquid preparation for a contact lens according to the present invention and used for adjustment of the osmotic pressure thereof there are generally used at least one or more compounds selected from the group consisting of sodium chloride, potassium chloride, a saccharide, a sugar alcohol and a polyol, or an ether or an ester thereof.
- Specific compounds thereof include glycerol, propylene glycol, polyethylene glycol, mannitol, sorbitol, dextrin, dextran and the like, in addition to the above-mentioned alkali metal chlorides.
- the osmotic pressure of the liquid preparation for a contact lens is generally adjusted to about 200 mOsm/kg to 400 mOsm/kg, using such a tonicity agent.
- the chelating agent is added for the purpose of inhibiting polyvalent metal ions such as calcium from depositing on or being adsorbed by the contact lens, or improving stability of the liquid preparation to advantageously intend long-term storage thereof, and various known agents are appropriately selected and used.
- ethylenediamine tetraacetic acid (EDTA) and salts thereof such as disodium ethylenediamine tetraacetate (EDTA-2Na), trisodium ethylenediamine tetraacetate (EDTA-3Na), for example.
- various known surfactants may be added to the liquid preparation for a contact lens according to the present invention to be contained therein for the purpose of enhancing cleaning properties of the contact lens, or in the case where the liquid preparation component to be contained is insoluble in water, for the purpose of stably dissolving (solubilizing) the component in the aqueous medium.
- surfactants there may be employed all of conventionally known anionic surfactants, nonionic surfactants, amphoteric surfactants and cationic surfactants, as long as they have a high degree of safety against living organisms and have no influence on the contact lens.
- the surfactants are advantageously added and contained at a concentration not impairing the functions and effects of the present invention.
- surfactants there are advantageously used, for example, polyoxyethylene-polyoxypropylene block copolymers and derivatives thereof, polyethylene glycol derivatives such as polyoxyethylene alkyl phenyl ether-formaldehyde condensates, such as tyloxapol, sorbitan fatty acid esters such as sorbitan sesquioleate, polyoxyethylene sorbitan fatty acid esters such as polyoxyethylene sorbitan monooleate (for example, Polysorbate 80), glycerin fatty acid esters such as glyceryl monostearate, polyethylene glycol fatty acid esters such as polyethylene glycol monostearate, polyoxyethylene alkyl ethers such as polyoxyethylene lauryl ether, polyoxyethylene castor oil, polyoxyethylene hydrogenated castor oil, polyoxyethylene alkyl ether carboxylic acids and salts thereof, and sucrose fatty acid esters.
- polyethylene glycol derivatives such as polyoxyethylene alkyl phenyl ether
- Pluronic, Pluronic R, Tetronic and Tetronic R are polyoxyethylene-polyoxypropylene block copolymers and commercially available as nonionic surfactants, specifically, Poloxamer 124, Poloxamer 188, Poloxamer 237, Poloxamer 338, Poloxamer 407, Tetronic 904, Tetronic 908, Tetronic 1304, Tetronic 1107, Polysorbate 80 which is polyoxyethylene sorbitan monooleate, polyoxyethylene hydrogenated castor oil, for example.
- the pH value or osmotic pressure thereof becomes too high or conversely too low, there is a risk of giving a stimulus to the eye or causing eye troubles. It is therefore generally desirable to adjust the pH value of the liquid preparation for a contact lens to about 6 to 8 and especially to around 7.0 by addition of an appropriate pH adjusting agent or buffer.
- the pH adjusting agent used for such pH adjustment there is used sodium hydroxide, hydrochloric acid, for example.
- the buffer for keeping the pH of the liquid preparation effectively within the above-mentioned range and within a range safe to the eye is appropriately selected from conventionally known various ones and used.
- acids such as phosphoric acid, boric acid, carboxylic acid, oxycarboxylic acid, and salts thereof (for example, sodium salts and the like), and further, Good-Buffer, tris(hydroxymethyl)aminomethane (TRIS), bis(2-hydroxyethyl)iminotris(hydroxymethyl)methane (Bis-Tris), sodium hydrogen carbonate and the like, because they are safe to the eye, and moreover, influences thereof on the contact lens can be decreased.
- TMS tris(hydroxymethyl)aminomethane
- Bis-Tris bis(2-hydroxyethyl)iminotris(hydroxymethyl)methane
- the liquid preparation for a contact lens according to the present invention is prepared by using the specific combination of the cationic polypeptide antimicrobial agent with Hypromellose 2910 as the thickening agent as described above, thereby being able to exhibit excellent characteristics as the liquid preparation for disinfecting a contact lens.
- a thickening agent or thickener other than Hypromellose 2910 within a quantitative range not impairing the effect owing to the use of the specific thickening agent.
- Such thickening agent includes, for example, various gums such as polysaccharides, mucopolysaccharides and heteropolysaccharides, such as condroitin sulfuric acid, hyaluronic acid, gluconic acid and salts thereof; synthetic organic high-molecular compounds such as polyvinyl alcohol, poly-N-vinylpyrrolidone, polyethylene glycol, polypropylene glycol and polyacrylamide; cellulose derivatives such as hydroxyethylcellulose, carboxymethyl-cellulose and methylcellulose; and starch derivatives.
- various gums such as polysaccharides, mucopolysaccharides and heteropolysaccharides, such as condroitin sulfuric acid, hyaluronic acid, gluconic acid and salts thereof
- synthetic organic high-molecular compounds such as polyvinyl alcohol, poly-N-vinylpyrrolidone, polyethylene glycol, polypropylene glycol and polyacrylamide
- cellulose derivatives such as hydroxyeth
- an anti-inflammatory agent for reducing intraocular inflammation caused by stress or by wearing the contact lens such as an anti-inflammatory agent for reducing intraocular inflammation caused by stress or by wearing the contact lens, a refrigerant for the purpose of releasing an irritating or itching sensation at the time of wearing the contact lens, and further various vitamins and amino acids, to the liquid preparation for a contact lens according to the present invention depending on the intended application thereof.
- the liquid preparation for a contact lens according to the present invention is prepared by adding the above-described components in respective proper amounts to an appropriate aqueous medium to be contained therein, in the same manner as the conventional one. It goes without saying that it is also possible to utilize as the aqueous medium, an isotonic sodium chloride solution or a sodium chloride-containing aqueous solution, a known liquid preparation for a contact lens or the like, in addition to water itself such as tap water, purified water or distilled water, as long as it is a solution mainly composed of water.
- additive components when other additive components are added to and dissolved in the predetermined aqueous medium in addition to the essential components of the cationic polypeptide antimicrobial agent and Hypromellose 2910 which are used according to the present invention, no particular technique is required to be employed at all. Addition and dissolution of the additive components can be easily performed by dissolving the respective components in the aqueous medium in the same manner as in the case where an ordinary aqueous solution is prepared. In particular, in the present invention, it is easy to perform the filtration sterilization processing to the aqueous solution obtained by dissolving these respective components, thereby making it possible to perform mass processing. Thus, the liquid preparation for a contact lens according to the present invention can be industrially advantageously obtained with good productivity, and accordingly in low production cost.
- the filtration sterilization processing of the aqueous solution is generally performed by filtration using a membrane filter having a pore size of about 0.1 ⁇ m to 10 ⁇ m. Further, a degerming processing is effectively realized by this filtration sterilization processing, together with removal of foreign matter from the solution, resulting in that the desired aseptic liquid preparation for a contact lens is advantageously obtained.
- the liquid preparation for a contact lens according to the present invention obtained as described above has a sufficient degree of safety to the eye and is easy to produce, whereby the productivity thereof is enhanced, and the liquid preparation is advantageously used as the liquid preparation for disinfecting a contact lens.
- the liquid preparation for a contact lens is advantageously used, for example, as a multi-purpose liquid preparation (multi-purpose solution: MPS) such as a cleaning-preservative solution, a cleaning-preservative-rinsing solution or a germicidal-cleaning solution, which can perform plural treatments with one kind of liquid preparation, as well as being able to be used as a germicidal or disinfecting solution for a contact lens, a cleaning solution for a contact lens, a preservative solution for a contact lens, a rinsing solution for a contact lens, for example.
- MPS multi-purpose liquid preparation
- the type of the contact lens to be treated with the liquid preparation for a contact lens according to the present invention is not limited in any way.
- the liquid preparation can be applied to soft contact lenses which are classified into all of non-water-content, low-water-content and high-water-content contact lenses, and hard contact lenses, for example.
- the material or the like of the contact lens does not become an issue in any way in the application of the present invention.
- Cationic hydrolyzed soybean protein (WS-HCAQ) Cationic hydrolyzed silk (S-CAQ) Comparative Disinfectant Polybiguanide PHMB (Cosmocil CQ) Arch Chemicals Inc. Polyquaternary ammonium P-4 (L-200) National Starch and Chemical Co. Polyquaternary ammonium P-10 (SC-230M) Kao Corp. Cationic guar gum (C-14S) Sansho Co., Ltd. Cationic dextran (CDC-L) Meito Sangyo Co., Ltd. Cationic trehalose Hayashibara Co., Ltd.
- PVP Kerdon K-90
- BASF SE PVA (Gohsenol EG-40) Nippon Synthetic Chemical Industry Co., Ltd.
- Tonicity Agent Propylene glycol Asahi Glass Co., Ltd.
- Predetermined ingredients were each added to sterilized purified water at various ratios shown in the following Tables 2 to 5, thereby preparing various test liquids (Nos. 1 to 24), respectively, adjusted to an initial pH of 7.4.
- each suspension was allowed to stand at 23°C for 4 hours, and then, 1 ml of the suspension was taken out.
- the disinfection efficacy of the respective test liquids was evaluated from the value of the above-mentioned logarithmic reduction (log reduction) of bacteria or fungi. With respect to evaluation criteria thereof, the case where First Criteria (for germiciding) in ISO 14729 were satisfied was evaluated as ⁇ , and the case where not satisfied was evaluated as x.
- a pre-cultured vegetative hypha of Acanthamoeba (Acanthamoeba castellanii ATCC50370) was collected from a flask, and a suspension of 5x10 5 cells/ml was prepared using 1/4 Ringer's solution.
- 5 ml of each test liquid was accommodated in a test tube, and 50 ⁇ l of the above-mentioned Acanthamoeba suspension was added thereto, followed by stirring to prepare a suspension finally containing 5x10 3 cells/ml of amebas.
- the kinematic viscosity of each test liquid was measured using an ubbelohde viscometer (manufactured by Shibata Scientific Technology, Ltd.). In that case, the ubbelohde viscometer having such a coefficient that the flow time in seconds becomes 200 to 1,000 seconds was selected. The measurement was conducted in a constant temperature bath at 25°C so as to have no change in temperature. Then, the kinematic viscosity (unit: mm 2 /s) was determined by the product of the flow time in seconds of each test liquid, which was measured with the ubbelohde viscometer, and the coefficient of the ubbelohde viscometer.
- test liquid Nos. 1 to 4, 6, 7 and 14 to 18 obtained by combining the polypeptide disinfectants with Hypromellose 2910 and adjusted in kinematic viscosity (25°C) to 0.8 mm 2 /s to 15 mm 2 /s according to the present invention show excellent disinfection effect and filterability.
- test liquid No. 5 adjusted in kinematic viscosity (25°C) to more than 15 mm 2 /s has poor filterability, and a filtration sterilization operation cannot be advantageously performed. Further, even when the polypeptide disinfectant is used, it has been observed that test liquid Nos.
- test liquids 3, 6, 13 to 15 and 19 prepared in the above-indicated Tables 2 to 4 the long-term stability of the respective test liquids was examined.
- test liquids 3, 6, 14 and 15 according to the present invention vary little in pH and also in the disinfection effect even after the storage at 45°C for 6 months, to exhibit the excellent disinfection effect.
- test liquid 13 using PVA as the thickening agent is excellent in the disinfection effect, but its liquid pH is significantly decreased by the long-term storage, giving rise to a problem with long-term storage stability.
- test liquid 19 using polybiguanide (PHMB) as the disinfectant it has become clear that the disinfection effect is significantly decreased by the long-term storage.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Eyeglasses (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Medicinal Preparation (AREA)
Description
- The present invention relates to a liquid preparation for a contact lens, and particularly to a liquid preparation for a contact lens, which is suitably used as a composition for disinfecting a contact lens, easily produced and excellent in stability.
- Antimicrobial agent-containing liquid preparations which have hitherto been used for disinfection and the like of contact lenses are generally produced as sterile preparations, and a process of achieving sterilization thereof is usually performed by sterilization by filtration, sterilization by an autoclave or a combination thereof.
- Of these, however, the autoclave sterilization employs a process of performing cooling after heating at 121 °C or more. Accordingly, in the case of the liquid preparation which contains a component having low thermal stability, the autoclave sterilization cannot be employed. Further, a heat-resistant and pressure-resistant production line and cooling equipment become necessary, so that there is also an inherent demerit that the production time becomes longer due to the heating and cooling process.
- In contrast, sterile processing by the filtration sterilization makes it possible to produce the liquid preparations at ordinary temperature, and has more advantages in production of the liquid preparations than the autoclave sterilization, when the liquid preparations have no problems with filterability and effects on a filter. Further, there is an advantage that foreign matter with which the liquid preparations are contaminated from raw materials and the production line can also be removed by the filter. Therefore, employment of the process of achieving sterilization by the filtration sterilization is usually studied as the first option. When some raw materials providing the liquid preparations have problems with filterability and the like in the sterile processing by the filtration sterilization, there is no choice but to employ a system in which only the components having poor filterability are subjected to the autoclave sterilization and the other components which are separately subjected to the filtration sterilization are aseptically mixed therewith, or a production system in which all components are mixed and subjected to the autoclave sterilization.
- On the other hand, in the liquid preparations for contact lenses, attempts have been made to blend various kinds of thickening agents in order to impart slipperiness at the time of scrubbing the lenses, a cushion effect at the time of wearing on the eyes, and a wetting action due to components adhered to surfaces of the lenses, for example. However, it has been known that such thickening agents are raw materials (components) which largely affect the filterability, stability and the like, giving rise to problems such as deterioration of the filterability and reduction of the long-term stability, depending on the kind thereof. Therefore, in selecting the thickening agent, it also becomes an important factor to judge from the viewpoints of not only feeling and an effect of the wetting action but also an influence on the stability and production cost of the liquid preparations.
- Generally, in the liquid preparations for disinfecting contact lenses, as the thickening agents, there are mainly used cellulose-based, guar gum-based, PVA-based and PVP-based ones, for example. However, at present, the thickening agents which can be processed by the filtration sterilization while imparting a certain degree of thickening effect to the liquid preparations are limited to the PVA-based thickening agents and some cellulose-based thickening agents (substitution type: HPMC 2910). Of these, the PVA-based thickening agents are extremely excellent in filterability. However, there is a problem that when the liquid preparations containing the PVA-based thickening agents are stored for a long period of time, acetic acid esters of unsaponified portions thereof are hydrolyzed, thereby causing a gradual decrease in the pH of the liquid preparations. Accordingly, in multi-purpose solutions which come into direct contact with the eye, there is an inherent problem that such a decrease in the pH causes eye irritation. From such a situation, in the production of the liquid preparations considering employment of the filtration sterilization processing process, the cellulose-based thickening agent (HPMC 2910) is considered to be the first option as the thickening agent.
- Further, as the liquid preparations for disinfecting contact lenses, one-liquid type multi-purpose solutions in which cationic disinfectants requiring no neutralization are blended at low concentrations have become the mainstream, instead of hydrogen peroxide-based disinfectants requiring neutralization. As the cationic disinfectants used in the multi-purpose solutions, two kinds of disinfectants are mainly intended: PHMB (polyhexamethylene biguanide) as a disinfectant of a biguanide-based polymer, and Polyquad as a disinfectant of a quaternary ammonium salt-based polymer. Of these, Polyquad is reported to have a low disinfection effect to fungi and amebas, so that it is considered that a low-molecular disinfectant having a high disinfection effect to fungi and amebas is used together with Polyquad. However, the low-molecular disinfectant has a problem of high toxicity. Furthermore, a problem caused by accumulation in the inside of lenses or the like is also a concern. On the other hand, PHMB has a high disinfection effect not only to bacteria but also to fungi and amebas, and is a well-balanced disinfectant, so that it has been used in many multi-purpose solutions.
- From such a situation, it is considered that when PHMB is used as the disinfectant and the cellulose-based thickening agent having high filterability is used as the thickening agent, it is possible to realize liquid preparation composition which can be subjected to the filtration sterilization. Unfortunately, however, when such a PHMB disinfectant is combined with the cellulose-based thickening agent (substitution type: HPMC 2910), some kind of reaction occurs therebetween to pose a problem in stability of a disinfection action by PHMB, resulting in a problem of decreasing the disinfection effect with time.
-
JP-T-8-504346 - Further, Japanese Patent No.
3813133 3693656 3693657 4255839 -
- Patent Document 1:
JP-T-8-504346 - Patent Document 2: Japanese Patent No.
3813133 - Patent Document 3: Japanese Patent No.
3693656 - Patent Document 4: Japanese Patent No.
3693657 - Patent Document 5: Japanese Patent No.
4255839 - The present invention has been made herein in the light of such situations. It is therefore a problem to be solved by the present invention to provide a liquid preparation for disinfecting a contact lens which preparation has excellent stability and can be advantageously produced by a process employing filtration sterilization. It is another problem to be solved by the present invention to provide a method of industrially advantageously producing the liquid preparation for disinfecting a contact lens which has such excellent characteristics.
- In order to solve the problems, the present inventors have made intensive studies, and as a result, have found that in the production of the liquid preparation for disinfecting a contact lens, use of a cationic polypeptide as an antimicrobial agent and use of the specific substitution type hydroxypropyl methyl-cellulose (HPMC), Hypromellose 2910, selected from various types of known HPMCs as the thickening agent make it possible to maintain a high disinfection effect to fungi, Acanthamoeba and the like for a long period of time and to industrially produce the liquid preparation by filtration sterilization, thus being able to solve all the inherent problems of the conventional liquid preparations for disinfecting contact lenses.
- The present invention has been completed on the basis of such findings, and the gist of the present invention is a liquid preparation for a contact lens comprising a cationic polypeptide antimicrobial agent and Hypromellose 2910 as a thickening agent, wherein a kinematic viscosity at 25°C thereof is adjusted to 0.8 mm2/s to 15 mm2/s.
- In one preferred embodiment of the liquid preparation for a contact lens according to the present invention, the above-mentioned cationic polypeptide antimicrobial agent is selected from the group consisting of polylysine, protamine, cationic collagen, cationic keratin, cationic soybean protein and cationic silk.
- Further, in the present invention, the cationic polypeptide antimicrobial agent is contained preferably at a ratio of 0.1 ppm to 10,000 ppm.
- Furthermore, in the liquid preparation for a contact lens according to the present invention, at least one of a tonicity agent, a chelating agent, a buffer and a surfactant may be contained as needed, in addition to the above-mentioned cationic polypeptide antimicrobial agent and Hypromellose 2910.
- In addition, in the liquid preparation for a contact lens according to the present invention, a pH thereof is preferably adjusted to the range of 6 to 8.
- It is also a gist of the present invention to employ a method of producing a liquid preparation for a contact lens comprising the steps of (a) preparing a solution by adding at least a cationic polypeptide antimicrobial agent and Hypromellose 2910 to an aqueous medium to be dissolved therein, and adjusting a kinematic viscosity of the solution at 25°C to 0.8 mm2/s to 15 mm2/s, and (b) sterilizing the resulting solution by filtering it using a membrane filter.
- As described above, in the liquid preparation for a contact lens according to the present invention, the specific substitution type HPMC, Hypromellose 2910, is combined as the thickening agent with the cationic polypeptide antimicrobial agent, and the liquid preparation is prepared so as to have the predetermined kinematic viscosity. Accordingly, the liquid preparation for a contact lens according to the present invention is characterized in that a high disinfection effect to fungi, Acanthamoeba and the like can be maintained over a long period of time, and the liquid pH can be stably maintained over a long period of time. Moreover, the filtration sterilization processing can be easily performed to the solution in which the cationic polypeptide antimicrobial agent and Hypromellose 2910 are dissolved and contained and which is adjusted to the predetermined kinematic viscosity, so that mass processing of the desired liquid preparation for a contact lens becomes possible, making it possible to perform the filtration sterilization processing advantageously in cost.
- Further, in the method of producing a liquid preparation for a contact lens according to the present invention, the filtration sterilization process can be employed. Therefore, mass processing becomes possible, and the filtering cost for removing foreign matter and the degerming cost to fungi, Acanthamoeba and the like can be advantageously reduced, thereby being able to largely contribute to a reduction of product cost. Thus, an industrially advantageous production method has been established.
- A liquid preparation for a contact lens according to the present invention has a major characteristic in that the preparation is mainly composed of an aqueous medium in which a cationic polypeptide antimicrobial agent and Hypromellose 2910 as a thickening agent are contained, and adjusted to a predetermined kinematic viscosity.
- Specifically, the cationic polypeptide antimicrobial agent used as an essential component in the present invention is known as a relatively high-molecular-weight disinfectant in a liquid preparation for disinfecting a contact lens, and components such as polylysine, protamine, cationic collagen, cationic keratin, cationic soybean protein and cationic silk are appropriately selected and used.
- In order to effectively exhibit an antimicrobial action to the contact lens thereby, the cationic polypeptide antimicrobial agent is generally contained in the liquid preparation for a contact lens at a ratio of 0.1 ppm to 10,000 ppm, and more preferably at a ratio of 1 ppm to 1,000 ppm. There is a risk that excessive inclusion of the antimicrobial agent causes a harmful action to the eye, so that it is desirable to avoid the excessive inclusion thereof.
- Further, Hypromellose 2910 which is another essential component of the liquid preparation for a contact lens according to the present invention is used as the thickening agent, and is one substitution type of a cellulose-based compound (hydroxypropyl methylcellulose: HPMC) having a structure in which hydrogen atoms of hydroxyl groups of cellulose are partially substituted with methyl groups (-CH3) or hydroxypropyl groups (-CH2CHOHCH3). Namely, Hypromellose 2910 used in the present invention contains methoxy groups in an amount of 28.0% to 30.0% and hydroxypropoxy groups in an amount of 7.0% to 12.0%, on the weight basis. Hypromellose 2910 has a high degree of safety against living organisms, and is ophthalmologically sufficiently allowable, while having no influence on the shape and physical properties of the contact lens.
- In the liquid preparation for a contact lens in which such Hypromellose 2910 is contained together with the cationic polypeptide antimicrobial agent, the kinematic viscosity thereof at 25°C is adjusted to 0.8 mm2/s to 15 mm2/s. When the kinematic viscosity excessively decreases, inconvenience occurs in use of the liquid preparation for a contact lens, because of an insufficient thickening effect thereof. On the other hand, when the kinematic viscosity excessively increases, it becomes difficult to perform the filtration sterilization processing of the liquid preparation. The kinematic viscosity is preferably within the range of 1 mm2/s to 10 mm2/s.
- In order to give the kinematic viscosity within such a range, the content of Hypromellose 2910 is appropriately adjusted depending on the viscosity grade used. In general, Hypromellose 2910 is added and contained within the range of about 0.01 % to 10%, preferably about 0.1% to 5%, on the weight basis.
- As described above, the liquid preparation for a contact lens according to the present invention is obtained by using the cationic polypeptide antimicrobial agent and the specific cellulose-based compound, Hypromellose 2910, as the thickening agent combined therewith, adding these two components to an appropriate aqueous medium to be dissolved therein in the same manner as the conventional liquid preparation for a contact lens, and adjusting the kinematic viscosity to the specific value. However, in the present invention, one, two or more of additive components described later, such as a tonicity agent, a chelating agent, a buffer and a surfactant which have been used in a common liquid preparation for a contact lens, may be appropriately selected and added at an ordinary addition ratio as needed, in addition to the two contained components of the cationic polypeptide antimicrobial agent and Hypromellose 2910. It is preferable that the additive components have a high degree of safety against living organisms, and are ophthalmologically sufficiently allowable, while having no influence on the shape and physical properties of the contact lens. It is desirable that the additive components are used within a quantitative range satisfying such requirements. This makes it possible to advantageously impart various functions depending on the additive components to the liquid preparation for a contact lens, without impairing the effects of the present invention in any way.
- For example, as the tonicity agent which is contained in the liquid preparation for a contact lens according to the present invention and used for adjustment of the osmotic pressure thereof, there are generally used at least one or more compounds selected from the group consisting of sodium chloride, potassium chloride, a saccharide, a sugar alcohol and a polyol, or an ether or an ester thereof. Specific compounds thereof include glycerol, propylene glycol, polyethylene glycol, mannitol, sorbitol, dextrin, dextran and the like, in addition to the above-mentioned alkali metal chlorides. It is preferred that the osmotic pressure of the liquid preparation for a contact lens is generally adjusted to about 200 mOsm/kg to 400 mOsm/kg, using such a tonicity agent.
- Further, the chelating agent is added for the purpose of inhibiting polyvalent metal ions such as calcium from depositing on or being adsorbed by the contact lens, or improving stability of the liquid preparation to advantageously intend long-term storage thereof, and various known agents are appropriately selected and used. Specifically, there can be used ethylenediamine tetraacetic acid (EDTA) and salts thereof such as disodium ethylenediamine tetraacetate (EDTA-2Na), trisodium ethylenediamine tetraacetate (EDTA-3Na), for example.
- Furthermore, various known surfactants may be added to the liquid preparation for a contact lens according to the present invention to be contained therein for the purpose of enhancing cleaning properties of the contact lens, or in the case where the liquid preparation component to be contained is insoluble in water, for the purpose of stably dissolving (solubilizing) the component in the aqueous medium. As such surfactants, there may be employed all of conventionally known anionic surfactants, nonionic surfactants, amphoteric surfactants and cationic surfactants, as long as they have a high degree of safety against living organisms and have no influence on the contact lens. The surfactants are advantageously added and contained at a concentration not impairing the functions and effects of the present invention.
- As specific examples of such surfactants, there are advantageously used, for example, polyoxyethylene-polyoxypropylene block copolymers and derivatives thereof, polyethylene glycol derivatives such as polyoxyethylene alkyl phenyl ether-formaldehyde condensates, such as tyloxapol, sorbitan fatty acid esters such as sorbitan sesquioleate, polyoxyethylene sorbitan fatty acid esters such as polyoxyethylene sorbitan monooleate (for example, Polysorbate 80), glycerin fatty acid esters such as glyceryl monostearate, polyethylene glycol fatty acid esters such as polyethylene glycol monostearate, polyoxyethylene alkyl ethers such as polyoxyethylene lauryl ether, polyoxyethylene castor oil, polyoxyethylene hydrogenated castor oil, polyoxyethylene alkyl ether carboxylic acids and salts thereof, and sucrose fatty acid esters. Among these, it is desirable to use in particular, Pluronic, Pluronic R, Tetronic and Tetronic R (the above are manufactured by BASF SE, Germany), which are polyoxyethylene-polyoxypropylene block copolymers and commercially available as nonionic surfactants, specifically, Poloxamer 124, Poloxamer 188, Poloxamer 237, Poloxamer 338, Poloxamer 407, Tetronic 904, Tetronic 908, Tetronic 1304, Tetronic 1107, Polysorbate 80 which is polyoxyethylene sorbitan monooleate, polyoxyethylene hydrogenated castor oil, for example.
- In addition, in the liquid preparation for a contact lens according to the present invention, when the pH value or osmotic pressure thereof becomes too high or conversely too low, there is a risk of giving a stimulus to the eye or causing eye troubles. It is therefore generally desirable to adjust the pH value of the liquid preparation for a contact lens to about 6 to 8 and especially to around 7.0 by addition of an appropriate pH adjusting agent or buffer.
- As the pH adjusting agent used for such pH adjustment, there is used sodium hydroxide, hydrochloric acid, for example. On the other hand, the buffer for keeping the pH of the liquid preparation effectively within the above-mentioned range and within a range safe to the eye is appropriately selected from conventionally known various ones and used. Specific examples thereof include acids such as phosphoric acid, boric acid, carboxylic acid, oxycarboxylic acid, and salts thereof (for example, sodium salts and the like), and further, Good-Buffer, tris(hydroxymethyl)aminomethane (TRIS), bis(2-hydroxyethyl)iminotris(hydroxymethyl)methane (Bis-Tris), sodium hydrogen carbonate and the like, because they are safe to the eye, and moreover, influences thereof on the contact lens can be decreased.
- The liquid preparation for a contact lens according to the present invention is prepared by using the specific combination of the cationic polypeptide antimicrobial agent with Hypromellose 2910 as the thickening agent as described above, thereby being able to exhibit excellent characteristics as the liquid preparation for disinfecting a contact lens. However, it is also possible to add a thickening agent or thickener other than Hypromellose 2910 within a quantitative range not impairing the effect owing to the use of the specific thickening agent. Such thickening agent includes, for example, various gums such as polysaccharides, mucopolysaccharides and heteropolysaccharides, such as condroitin sulfuric acid, hyaluronic acid, gluconic acid and salts thereof; synthetic organic high-molecular compounds such as polyvinyl alcohol, poly-N-vinylpyrrolidone, polyethylene glycol, polypropylene glycol and polyacrylamide; cellulose derivatives such as hydroxyethylcellulose, carboxymethyl-cellulose and methylcellulose; and starch derivatives.
- Further, in addition to the above-described components, it is possible to appropriately add pharmaceutical components similar to the conventional ones, such as an anti-inflammatory agent for reducing intraocular inflammation caused by stress or by wearing the contact lens, a refrigerant for the purpose of releasing an irritating or itching sensation at the time of wearing the contact lens, and further various vitamins and amino acids, to the liquid preparation for a contact lens according to the present invention depending on the intended application thereof.
- The liquid preparation for a contact lens according to the present invention is prepared by adding the above-described components in respective proper amounts to an appropriate aqueous medium to be contained therein, in the same manner as the conventional one. It goes without saying that it is also possible to utilize as the aqueous medium, an isotonic sodium chloride solution or a sodium chloride-containing aqueous solution, a known liquid preparation for a contact lens or the like, in addition to water itself such as tap water, purified water or distilled water, as long as it is a solution mainly composed of water.
- Further, when other additive components are added to and dissolved in the predetermined aqueous medium in addition to the essential components of the cationic polypeptide antimicrobial agent and Hypromellose 2910 which are used according to the present invention, no particular technique is required to be employed at all. Addition and dissolution of the additive components can be easily performed by dissolving the respective components in the aqueous medium in the same manner as in the case where an ordinary aqueous solution is prepared. In particular, in the present invention, it is easy to perform the filtration sterilization processing to the aqueous solution obtained by dissolving these respective components, thereby making it possible to perform mass processing. Thus, the liquid preparation for a contact lens according to the present invention can be industrially advantageously obtained with good productivity, and accordingly in low production cost. It is recommended that the filtration sterilization processing of the aqueous solution is generally performed by filtration using a membrane filter having a pore size of about 0.1 µm to 10 µm. Further, a degerming processing is effectively realized by this filtration sterilization processing, together with removal of foreign matter from the solution, resulting in that the desired aseptic liquid preparation for a contact lens is advantageously obtained.
- The liquid preparation for a contact lens according to the present invention obtained as described above has a sufficient degree of safety to the eye and is easy to produce, whereby the productivity thereof is enhanced, and the liquid preparation is advantageously used as the liquid preparation for disinfecting a contact lens. The liquid preparation for a contact lens is advantageously used, for example, as a multi-purpose liquid preparation (multi-purpose solution: MPS) such as a cleaning-preservative solution, a cleaning-preservative-rinsing solution or a germicidal-cleaning solution, which can perform plural treatments with one kind of liquid preparation, as well as being able to be used as a germicidal or disinfecting solution for a contact lens, a cleaning solution for a contact lens, a preservative solution for a contact lens, a rinsing solution for a contact lens, for example.
- The type of the contact lens to be treated with the liquid preparation for a contact lens according to the present invention is not limited in any way. The liquid preparation can be applied to soft contact lenses which are classified into all of non-water-content, low-water-content and high-water-content contact lenses, and hard contact lenses, for example. The material or the like of the contact lens does not become an issue in any way in the application of the present invention.
- The present invention will be described more specifically showing some examples, but it goes without saying that the present invention is by no means restricted by descriptions of such examples. In addition to the following examples and further the above-mentioned specific descriptions, it should be understood that various changes, modifications and improvements may be made to the present invention, based on knowledge of those skilled in the art, without departing from the spirit and scope of the present invention.
- First, in order to prepare many test liquids as liquid preparations for a contact lens according to the present invention, and as liquid preparations for a contact lens according to comparative examples, various disinfectants (polypeptides), various comparative disinfectants, various thickening agents, a chelating agent, a surfactant, a buffer and a tonicity agent shown in Table 1 were each obtained from the companies shown in Table 1.
[TABLE 1] Ingredients Source Disinfectant (Polypeptide) ε-Polylysine Chisso Corp. Protamine sulfate Wako Pure Chemical Industries Ltd. Cationic hydrolyzed collagen (W42-CAQ) Cationic hydrolyzed keratin (WK-HCAQ) Seiwa Kasei Co. Ltd. Cationic hydrolyzed soybean protein (WS-HCAQ) Cationic hydrolyzed silk (S-CAQ) Comparative Disinfectant Polybiguanide PHMB (Cosmocil CQ) Arch Chemicals Inc. Polyquaternary ammonium P-4 (L-200) National Starch and Chemical Co. Polyquaternary ammonium P-10 (SC-230M) Kao Corp. Cationic guar gum (C-14S) Sansho Co., Ltd. Cationic dextran (CDC-L) Meito Sangyo Co., Ltd. Cationic trehalose Hayashibara Co., Ltd. Thickening Agent Hypromellose 2910, viscosity G=4000 (60SH-4000) Hypromellose 2910, viscosity G=50 (60SH-50) Hypromellose 2910, viscosity G=3 (TC-5E) Shin-Etsu Chemical Co., Ltd. Hypromellose 2906, viscosity G=4000 (65SH-4000) Hypromellose 2208, viscosity G=4000 (90SH-4000) Methylcellulose, viscosity G=4000 (SM-4000) Hydroxyethylcellulose (SE-400) Daicel Corp. PVP (Kollidon K-90) BASF SE PVA (Gohsenol EG-40) Nippon Synthetic Chemical Industry Co., Ltd. Chelating Agent EDTA·2Na Nagase Chemtex Corp. Surfactant Poloxamer 407 BASF SE Buffer Boric acid Tomiyama Pure Chemical Industries, Ltd. Tonicity Agent Propylene glycol Asahi Glass Co., Ltd. - Predetermined ingredients were each added to sterilized purified water at various ratios shown in the following Tables 2 to 5, thereby preparing various test liquids (Nos. 1 to 24), respectively, adjusted to an initial pH of 7.4.
- Then, for each of the obtained various test liquids (Nos. 1 to 24), the disinfection effect (4 hours), filterability and kinematic viscosity (25°C) were examined according to the following disinfection test method of bacteria (Pseudomonas aeruginosa) and fungi (Candida), disinfection test method of amebas, measuring method of kinematic viscosity and evaluation method of filterability. The results thereof are shown together in the following Tables 2 to 5.
- The following test was performed according to the guide line of ISO 14729 specifying the test method of a disinfection effect to contact lens-care products.
- First, using the respective test liquids prepared as described above, 9.9 ml of each liquid was accommodated in a test tube, and 0.1 ml of a bacterial or fungi liquid containing Pseudomonas aeruginosa (Pseudomonas aeruginosa NBRC 13275) or Candida albicans (Candida albicans IFO 1594) at a ratio of 108 cfu/ml to 109 cfu/ml was added thereto, followed by stirring to prepare a bacterial or fungi suspension corresponding to each test liquid, finally containing 106 cfu/ml to 107 cfu/ml of bacteria or fungi. Thereafter, each suspension was allowed to stand at 23°C for 4 hours, and then, 1 ml of the suspension was taken out. Using 20 ml of glucose-peptone agar medium, the viable cell count per ml of sample was measured by a plate dilution method. Then, from this viable cell count, the viable cell count per ml of each suspension was calculated, and thereafter, a logarithmic reduction (log reduction) of bacteria or fungi was determined according to the following equation:
- The disinfection efficacy of the respective test liquids was evaluated from the value of the above-mentioned logarithmic reduction (log reduction) of bacteria or fungi. With respect to evaluation criteria thereof, the case where First Criteria (for germiciding) in ISO 14729 were satisfied was evaluated as ○, and the case where not satisfied was evaluated as x.
- A pre-cultured vegetative hypha of Acanthamoeba (Acanthamoeba castellanii ATCC50370) was collected from a flask, and a suspension of 5x105 cells/ml was prepared using 1/4 Ringer's solution. On the other hand, 5 ml of each test liquid was accommodated in a test tube, and 50 µl of the above-mentioned Acanthamoeba suspension was added thereto, followed by stirring to prepare a suspension finally containing 5x103 cells/ml of amebas. Then, after each suspension was allowed to stand at 22°C for 4 hours, 20 µl of such ameba suspension was collected, and 10-fold serial dilution was appropriately performed by a method of mixing the suspension with 180 µl of lecithin polysorbate (LP)-added 1/4 Ringer's solution as a neutralizing agent. Then, 50 µl of a suspension of Escherichia coli prepared to 1x108 cfu was added to each test liquid subjected to the 10-fold serial dilution, followed by cultivation for 14 days. Then, the number of viable amebas was measured from the number of wells in which ameba multiplication was observed, and the log reduction value was calculated according to the following equation:
- The kinematic viscosity of each test liquid was measured using an ubbelohde viscometer (manufactured by Shibata Scientific Technology, Ltd.). In that case, the ubbelohde viscometer having such a coefficient that the flow time in seconds becomes 200 to 1,000 seconds was selected. The measurement was conducted in a constant temperature bath at 25°C so as to have no change in temperature. Then, the kinematic viscosity (unit: mm2/s) was determined by the product of the flow time in seconds of each test liquid, which was measured with the ubbelohde viscometer, and the coefficient of the ubbelohde viscometer.
- Using a membrane filter (manufactured by Nihon Pall Ltd., Supor EKV, pore size: 0.2 µm) having a diameter of 47 mm, after it was set to an inline stainless filter holder (manufactured by Nihon Millipore K.K., effective area: 13.8 cm2) for a 47 mm disk, filtration was performed for the respective test liquids at a pressure of 1 kgf/cm2, and the amounts of filtration after 3 hours were compared. The case where the amount of filtration after 3 hours was 2 litters or more was evaluated as ⊚, the case where it was 1 litter or more was evaluated as ○, the case where it was between 500 ml and 1 litter was evaluated as Δ, and the case where it was less than 500 ml was evaluated as x.
[TABLE 2] Test Liquid 1 2 3 4 5 6 7 Content (% by weight) Disinfectant (Polypeptide) ε-Polylysine 0.02 0.02 0.02 0.02 0.02 0.02 0.02 Thickening Agent Hypromellose 2910, viscosity G=4000 0.10 0.30 0.30 0.40 0.45 - - Hypromellose 2910, viscosity G=50 - - - - - 1.00 - Hypromellose 2910, viscosity G=3 - - - - - - 3.50 Chelating Agent EDTA·2Na - - 0.05 - - 0.05 0.05 Surfactant Poloxamer 407 - - 0.10 - - 0.10 0.10 Buffer Boric acid - - 0.10 - - 0.10 0.10 Tonicity Agent Propylene glycol - - 2.00 - - 2.00 2.00 Disinfection Effect (4 hours) Bacteria (P.aeruginosa) >4.7 >4.7 >4.7 >4.7 >4.7 >4.7 >4.7 Fungus (C.albicans) >4.9 4.9 >4.9 >4.9 >4.9 >4.9 >4.9 Ameba (A.Casteranni) >2.8 >2.8 >2.8 >2.8 >2.8 >2.8 >2.8 Filterability ⊚ ⊚ ⊚ ○ × ⊚ ⊚ Kinematic Viscosity (25°C)(mm2/s) 2.1 7.8 8.0 13.2 17.5 4.5 5.7 [TABLE 3] Test Liquid 8 9 10 11 12 13 Content (% by weight) Disinfectant (Polypeptide) ε-Polylysine 0.02 0.02 0.02 0.02 0.02 0.02 Thickening Agent Hypromellose 2906, viscosity G=4000 0.25 - - - - - Hypromellose 2208, viscosity G=4000 - 0.30 - - - - Methylcellulose, viscosity G=4000 - - 0.15 - - - Hydroxyethylcellulose - - - 0.60 - - PVP - - - - 2.00 - PVA - - - - - 1.50 Chelating Agent EDTA·2Na - - - 0.05 0.05 0.05 Surfactant Poloxamer 407 - - - 0.10 0.10 0.10 Buffer Boric acid - - - 0.10 0.10 0.10 Tonicity Agent Propylene glycol - - - 2.00 2.00 2.00 Disinfection Effect (4 hours) Bacteria (P.aeruginosa) >4.7 >4.7 >4.7 >4.7 >4.7 >4.7 Fungus (C.albicans) >4.9 >4.9 >4.9 >4.9 >4.9 >4.9 Ameba (A.Casteranni) >2.8 >2.8 >2.8 >2.8 >2.8 >2.8 Filterability × × × × × ⊚ Kinematic Viscosity (25°C)(mm2/s) 4.5 8.4 1.4 10.2 6.8 4.6 [TABLE 4] Test Liquid 14 15 16 17 18 19 Content (% by weight) Disinfectant (Polypeptide) Protamine sulfate 0.15 - - - - - Cationic hydrolyzed collagen - 0.05 - - - - Cationic hydrolyzed keratin - - 0.01 - - - Cationic hydrolyzed soybean protein - - - 0.01 - - Cationic hydrolyzed silk - - - - 0.01 - Comparative Disinfectant Polybiguanide (PHMB) - - - - - 0.005 Thickening Agent Hypromellose 2910, viscosity G=4000 0.30 0.30 0.30 0.30 0.30 0.30 Chelating Agent EDTA·2Na 0.05 0.05 - - - 0.05 Surfactant Poloxamer 407 0.10 0.10 - - - 0.10 Buffer Boric acid 0.10 0.10 - - - 0.10 Tonicity Agent Propylene glycol 2.00 2.00 - - - 2.00 Disinfection Effect (4 hours) Bacteria (P.aeruginosa) >4.7 >4.7 >4.7 >4.7 >4.7 >4.7 Fungus (C.albicans) >4.9 >4.9 >4.9 >4.9 >4.9 >4.9 Ameba (A. Casteranni) 2.4 1.8 2.5 1.4 >2.8 >2.8 Filterability ⊚ ⊚ ⊚ ⊚ ⊚ ⊚ Kinematic Viscosity (25°C)(mm2/s) 7.8 7.9 7.8 7.8 7.8 7.8 [TABLE 5] Test Liquid 20 21 22 23 24 Content (% by weight) Comparative Disinfectant Polyquaternary ammonium P-4 0.01 - - - - Polyquaternary ammonium P-10 - 0.10 - - - Cationic guar gum (C-14S) - - 0.05 - - Cationic dextran (CDC-L) - - - 0.10 Cationic trehalose - - - - 0.10 Thickening Agent Hypromellose 2910, viscosity G=4000 0.30 0.30 0.30 0.30 0.30 Disinfection Effect (4 hours) Bacteria (P.aeruginosa) >4.7 >4.7 >4.7 >4.7 0.2 Fungus (C.albicans) >4.9 0.6 4.3 0.8 -0.1 Ameba (A.Casterannl) 2.5 0.2 2.6 0.1 0.0 Filterability × × × ○ ⊚ Kinematic Viscosity (25°C)(mm2/s) 7.9 14.1 8.4 8.1 7.9 - As is apparent from the results of Tables 2 to 5, it has been observed that test liquid Nos. 1 to 4, 6, 7 and 14 to 18 obtained by combining the polypeptide disinfectants with Hypromellose 2910 and adjusted in kinematic viscosity (25°C) to 0.8 mm2/s to 15 mm2/s according to the present invention show excellent disinfection effect and filterability. In contrast, test liquid No. 5 adjusted in kinematic viscosity (25°C) to more than 15 mm2/s has poor filterability, and a filtration sterilization operation cannot be advantageously performed. Further, even when the polypeptide disinfectant is used, it has been observed that test liquid Nos. 8 to 12 using Hypromellose 2906 or 2208 different from Hypromellose 2910 in substitution type, methylcellulose, hydroxyethylcellulose or PVP, have poor filterability, even when the kinematic viscosity (25°C) is lower than 15 mm2/s. Further, it has been observed that test liquid Nos. 20 to 24 using the disinfectants (comparative disinfectants) other than the polypeptide disinfectant are insufficient in either the disinfection effect or filterability, and of no practical use.
- Using test liquids 3, 6, 13 to 15 and 19 prepared in the above-indicated Tables 2 to 4, the long-term stability of the respective test liquids was examined.
- Specifically, after each test liquid was stored at 45°C for 6 months, the disinfection effect was examined in the same manner as described above, and the pH value of each test liquid was measured. The results thereof are shown in Table 6, in which the disinfection effect is shown in comparison with the disinfection effect shown in the above-mentioned Tables 2 to 4, and the pH value is shown in comparison with the pH value immediately after the preparation of each test liquid.
[TABLE 6] Test Liquid 3 6 13 14 15 19 Content (% by weight) Disinfectant (Polypeptide) ε-Polylysine 0.02 0.02 0.02 - - - Protamine sulfate - - - 0.15 - - Cationic hydrolyzed collagen - - - - 0.05 - Comparative Disinfectant Polybiguanide (PHMB) - - - - - 0.005 Thickening Agent HPMC 2910, viscosity G=4000 0.30 - - 0.30 0.30 0.30 HPMC 2910, viscosity G=50 - 1.00 - - - - PVA - - 1.50 - - - Chelating Agent EDTA·2Na 0.05 0.05 0.05 0.05 0.05 0.05 Surfactant Poloxamer 407 0.10 0.10 0.10 0.10 0.10 0.10 Buffer Boric acid 0.10 0.10 0.10 0.10 0.10 0.10 Tonicity Agent Propylene glycol 2.00 2.00 2.00 2.00 2.00 2.00 Disinfection Effect (4 hours) Bacteria (P.aeruginosa) >4.7 >4.7 >4.7 >4.7 >4.7 >4.7 Fungus (C.albicans) >4.9 >4.9 >4.9 >4.9 >4.9 >4.9 Ameba (A. Casteranni) >2.8 >2.8 >2.8 2.4 1.8 >2.8 Disinfection Effect (45°C-after 6 months) Bacteria (P.aeruginosa) >4.7 >4.7 >4.7 >4.7 >4.7 >4.7 Fungus (C.albicans) >4.9 >4.9 >4.9 3.1 1.8 0.7 Ameba (A.Casteranni) >2.8 >2.8 >2.8 1.6 1.2 0.4 Comprehensive Evaluation ⊚ ⊚ ⊚ ○ ○ × pH Immediately after Preparation of Test Liquid 7.4 7.4 7.4 7.4 7.4 7.4 After Storage at 45°C for 6 Months 7.3 7.2 5.2 7.2 7.3 7.4 Comprehensive Evaluation ○ ○ × ○ ○ ○ - As is apparent from the results of Table 6, it has been observed that test liquids 3, 6, 14 and 15 according to the present invention vary little in pH and also in the disinfection effect even after the storage at 45°C for 6 months, to exhibit the excellent disinfection effect. In contrast, it has become clear that test liquid 13 using PVA as the thickening agent is excellent in the disinfection effect, but its liquid pH is significantly decreased by the long-term storage, giving rise to a problem with long-term storage stability. Further, in the case of test liquid 19 using polybiguanide (PHMB) as the disinfectant, it has become clear that the disinfection effect is significantly decreased by the long-term storage.
Claims (6)
- A liquid preparation for a contact lens comprising a cationic polypeptide antimicrobial agent and Hypromellose 2910 as a thickening agent, wherein a kinematic viscosity at 25°C thereof is adjusted to 0.8 mm2/s to 15 mm2/s.
- The liquid preparation for a contact lens according to claim 1, wherein the cationic polypeptide antimicrobial agent is selected from the group consisting of polylysine, protamine, cationic collagen, cationic keratin, cationic soybean protein and cationic silk.
- The liquid preparation for a contact lens according to claim 1 or 2, wherein the cationic polypeptide antimicrobial agent is contained at a ratio of 0.1 ppm to 10,000 ppm.
- The liquid preparation for a contact lens according to any one of claims 1 to 3, wherein at least one of a tonicity agent, a chelating agent, a buffer, a pH adjusting agent and a surfactant is further contained.
- The liquid preparation for a contact lens according to any one of claims 1 to 4, wherein a pH thereof is from 6 to 8.
- A method of producing the liquid preparation for a contact lens according to any one of claims 1 to 5 comprising the steps of:preparing a solution by adding at least a cationic polypeptide antimicrobial agent and Hypromellose 2910 to an aqueous medium to be dissolved therein, and adjusting a kinematic viscosity of the solution at 25°C to 0.8 mm2/s to 15 mm2/s; andsterilizing the resulting solution by filtering it using a membrane filter.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2011/050845 WO2012098653A1 (en) | 2011-01-19 | 2011-01-19 | Liquid preparation for contact lenses |
Publications (3)
Publication Number | Publication Date |
---|---|
EP2666484A1 EP2666484A1 (en) | 2013-11-27 |
EP2666484A4 EP2666484A4 (en) | 2015-08-19 |
EP2666484B1 true EP2666484B1 (en) | 2016-11-30 |
Family
ID=46515305
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP11856120.8A Active EP2666484B1 (en) | 2011-01-19 | 2011-01-19 | Liquid preparation for contact lenses |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP2666484B1 (en) |
JP (1) | JP5613779B2 (en) |
CN (1) | CN103370087A (en) |
WO (1) | WO2012098653A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018187617A1 (en) * | 2017-04-06 | 2018-10-11 | Amicrobe, Inc. | Compositions and uses of locally applied antimicrobials with enhanced performance and safety |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5894457B2 (en) * | 2012-02-22 | 2016-03-30 | 株式会社Adeka | Peptide-containing antibacterial composition |
CA2867903C (en) * | 2012-03-23 | 2023-02-14 | Amicrobe, Inc. | Compositions and uses of antimicrobial materials with tissue-compatible properties |
WO2014091575A1 (en) * | 2012-12-12 | 2014-06-19 | 株式会社メニコン | Antiseptic solution for ionic soft contact lens |
WO2014091574A1 (en) * | 2012-12-12 | 2014-06-19 | 株式会社メニコン | Disinfectant solution for nonionic soft contact lenses |
JP6260042B2 (en) * | 2013-05-27 | 2018-01-17 | 学校法人玉川学園 | Anti-acanthamoeba composition and ophthalmic agent containing the anti-acanthamoeba composition |
US10369237B2 (en) * | 2014-03-10 | 2019-08-06 | 3-D Matrix, Ltd. | Sterilization and filtration of peptide compositions |
US20150366311A1 (en) * | 2014-06-19 | 2015-12-24 | Coopervision International Holding Company, Lp | Protection of Contact Lenses from Microbial Contamination Caused by Handling |
CN106456710A (en) * | 2014-06-20 | 2017-02-22 | 库柏维景国际控股公司 | Ophthalmic composition for treatment of ocular infection |
CN107789657A (en) * | 2016-08-30 | 2018-03-13 | 欧普康视科技股份有限公司 | A kind of contact lens,hard conditioning liquid |
EP3722867A4 (en) | 2017-12-04 | 2021-08-11 | NOF Corporation | Soft contact lens treatment solution |
CN110200015B (en) * | 2019-05-21 | 2020-10-30 | 乐清市泰博恒电子科技有限公司 | Antiviral biological peptide care solution and preparation method and application thereof |
JPWO2023074596A1 (en) | 2021-10-29 | 2023-05-04 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2151136A1 (en) | 1992-12-09 | 1994-06-23 | Charles Hayes Powell | Cleaning compositions and methods for hydrophilic contact lenses |
US6482799B1 (en) * | 1999-05-25 | 2002-11-19 | The Regents Of The University Of California | Self-preserving multipurpose ophthalmic solutions incorporating a polypeptide antimicrobial |
KR20020069224A (en) * | 1999-12-27 | 2002-08-29 | 산텐 세이야꾸 가부시키가이샤 | System for stabilizing lacrimal fluid layer |
JP2003137775A (en) * | 2001-10-31 | 2003-05-14 | Menicon Co Ltd | Ophthalmic composition |
US20040028645A1 (en) * | 2001-12-13 | 2004-02-12 | Masood Chowhan | Artificial tear composition adapted to be used with contact lenses |
CA2443472A1 (en) | 2002-02-07 | 2003-08-14 | Ophtecs Corporation | Liquid formulation for contact lenses |
JP3693657B2 (en) | 2003-04-16 | 2005-09-07 | 旭化成アイミー株式会社 | Contact lens solution |
JP3813133B2 (en) | 2003-04-16 | 2006-08-23 | 旭化成アイミー株式会社 | Contact lens solution |
JP3693656B2 (en) | 2003-04-16 | 2005-09-07 | 旭化成アイミー株式会社 | Contact lens solution |
WO2005025539A1 (en) * | 2003-09-10 | 2005-03-24 | Senju Pharmaceutical Co., Ltd. | Ophthalmic composition for contact lens |
US7897553B2 (en) * | 2006-10-23 | 2011-03-01 | Bausch & Lomb Incorporated | Biguanide composition with low terminal amine |
JP2010204597A (en) * | 2009-03-06 | 2010-09-16 | Lion Corp | Composition for soft contact lens, and method for suppressing adsorption to soft contact lens |
WO2010141831A1 (en) * | 2009-06-05 | 2010-12-09 | Aciex Therapeutics, Inc. | Ophthalmic formulations, methods of manufacture, and methods of using same |
-
2011
- 2011-01-19 WO PCT/JP2011/050845 patent/WO2012098653A1/en active Application Filing
- 2011-01-19 JP JP2012553501A patent/JP5613779B2/en active Active
- 2011-01-19 EP EP11856120.8A patent/EP2666484B1/en active Active
- 2011-01-19 CN CN2011800654700A patent/CN103370087A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018187617A1 (en) * | 2017-04-06 | 2018-10-11 | Amicrobe, Inc. | Compositions and uses of locally applied antimicrobials with enhanced performance and safety |
Also Published As
Publication number | Publication date |
---|---|
EP2666484A1 (en) | 2013-11-27 |
WO2012098653A1 (en) | 2012-07-26 |
CN103370087A (en) | 2013-10-23 |
JPWO2012098653A1 (en) | 2014-06-09 |
EP2666484A4 (en) | 2015-08-19 |
JP5613779B2 (en) | 2014-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2666484B1 (en) | Liquid preparation for contact lenses | |
JP4001459B2 (en) | Multipurpose contact lens care composition | |
JP4084997B2 (en) | Improved ophthalmic and contact lens solutions containing simple sugars as preservative enhancers | |
US20070059332A1 (en) | Multi purpose contact lens care compositions including propylene glycol or glycerin | |
EP2130527A1 (en) | Ophthalmic compositions with an amphoteric surfactant and hyaluronic acid | |
US20020018732A1 (en) | Preserving compositions containing chitosan and processes for making water soluble O-acetylated chitosan and chitosan | |
JPH06504044A (en) | Disinfection methods and compositions for contact lenses | |
US20090196845A1 (en) | Opthalmic compositions with an amphoteric surfactant and an anionic biopolymer | |
US7683039B2 (en) | Water soluble, randomly substituted partial N-, partial O-acetylated chitosan, preserving compositions containing chitosan, and processes for making thereof | |
WO2009117056A1 (en) | Phosphate buffered ophthalmic solutions displaying improved efficacy | |
US7364723B1 (en) | Liquid preparation for contact lenses | |
EP1976571B1 (en) | Improving disinfection efficacy of lens care regimen for rigid gas permeable contact lenses | |
EP1656955B1 (en) | Liquid preparation for contact lens | |
EP1687036B1 (en) | Stability enhancement of solutions containing antimicrobial agents | |
US9125405B2 (en) | Contact lens solution with a tertiary amine oxide | |
EP3417885B1 (en) | Anti-acanthamoeba solvent for contact lenses | |
US20160136320A1 (en) | Lens care product for ozone-based cleaning/disinfecting of contact lenses | |
EP2664665B1 (en) | Ophthalmic compositions with biguanide and PEG-glycerol esters | |
US20110151017A1 (en) | Ophthalmic solutions with improved disinfection profiles | |
EP2263699B1 (en) | Solution composition for contact lenses | |
EP2262521B1 (en) | Ophthalmic compositions comprising a dipeptide with a glycine moiety | |
EP2968640B1 (en) | Synergistic ophthalmic compositions for disinfecting contact lenses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20130614 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAX | Request for extension of the european patent (deleted) | ||
RA4 | Supplementary search report drawn up and despatched (corrected) |
Effective date: 20150717 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: C11D 3/37 20060101ALI20150713BHEP Ipc: G02C 13/00 20060101ALI20150713BHEP Ipc: C11D 3/22 20060101ALI20150713BHEP Ipc: A61L 2/18 20060101AFI20150713BHEP Ipc: C11D 3/38 20060101ALI20150713BHEP Ipc: C11D 3/48 20060101ALI20150713BHEP Ipc: C11D 3/00 20060101ALI20150713BHEP |
|
17Q | First examination report despatched |
Effective date: 20160114 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
INTG | Intention to grant announced |
Effective date: 20160708 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 849195 Country of ref document: AT Kind code of ref document: T Effective date: 20161215 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602011033015 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 7 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: FP |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20161130 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 849195 Country of ref document: AT Kind code of ref document: T Effective date: 20161130 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20161130 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170301 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20161130 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170228 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20161130 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170330 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20161130 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20161130 Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170131 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20161130 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20161130 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20161130 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20161130 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20161130 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20161130 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20161130 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20161130 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20161130 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170228 Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20161130 Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20161130 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL Ref country code: DE Ref legal event code: R097 Ref document number: 602011033015 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20161130 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170131 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170131 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
26N | No opposition filed |
Effective date: 20170831 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170119 Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20161130 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 8 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170119 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170119 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20110119 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20161130 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20161130 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20161130 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20161130 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170330 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20240119 Year of fee payment: 14 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20240119 Year of fee payment: 14 Ref country code: GB Payment date: 20240119 Year of fee payment: 14 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20240124 Year of fee payment: 14 |